ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's Laboratories consolidated net profit declines 0.90% in the June 2024 quarter
Sales rise 13.87% to Rs 7672.70 crore
Announcement as on 27 July 2024

Dr Reddy’s Laboratories board announces 1:5 stock split
Additionally the company has also announced that each American Depositary Share (ADS) will still represent 1 equity share. As a result, the number of ADSs held by each American Depositary Receipt holder will increase in proportion to the increase in equity
Announcement as on 27 July 2024

Dr Reddy's Q1 Preview: PAT may fall 4% YoY on pricing pressure, subdued US sales
Pharma major Dr Reddy's faced a challenging first quarter, impacted by weak US sales due to heightened competition and pricing pressures. Analysts expect a 4% decline in net profit year-on-year despite an 8% increase in revenues. Higher Revlimid sales migh
Announcement as on 26 July 2024

Stocks to Watch, July 24: HUL, Bajaj Fin, L&T, Dr Reddy's, Vedanta, Axis Bk
Stocks to Watch today, Wednesday, July 24, 2024: HUL reported a 2.2 per cent Y-o-Y rise in consolidated net profit at Rs 2,610 crore for Q1FY25, in line with market expectations
Announcement as on 24 July 2024

Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drug
New Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg and 20mg Vonoprazan tablets, a PCAB for reflux esophagitis and acid peptic disorders, in India. CEO MV Ramana highli
Announcement as on 18 July 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.06
  • 12Day Average: 13.3
  • 20Day Average: 13.37
  • 50Day Average: 13.56
  • 100Day Average: 13.74
  • 150Day Average: 13.83
  • 200Day Average: 13.93

RDY Indicators & signals

Indicator MACD (12,26,9)

13.25, 13.36, -0.09
Indicator MACD is in negative zone

Indicator ADX (14)

0, 30, 30
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Thu May 2026 13.49 13.28 to 13.65 3.85% 0.89 times
13 Wed May 2026 12.99 12.74 to 13.00 4.25% 1.78 times
12 Tue May 2026 12.46 12.19 to 12.74 -5.18% 1.68 times
11 Mon May 2026 13.14 13.11 to 13.29 -0.68% 0.91 times
08 Fri May 2026 13.23 13.22 to 13.56 -1.49% 0.69 times
07 Thu May 2026 13.43 13.43 to 13.65 -0.22% 0.85 times
06 Wed May 2026 13.46 13.40 to 13.72 0% 1.17 times
06 Wed May 2026 13.46 13.40 to 13.72 1.51% 1.17 times
05 Tue May 2026 13.26 13.21 to 13.39 -0.67% 0.49 times
04 Mon May 2026 13.35 13.27 to 13.55 -2.7% 0.68 times
01 Fri May 2026 13.72 13.64 to 13.81 0.59% 0.58 times
30 Thu Apr 2026 13.64 13.64 to 13.81 -0.66% 0.61 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

 

Back to top